Ronald A. Herman, Ph.D. College of Pharmacy, University of Iowa

Course Materials and Clerkships

Pharmacokinetic Topics

Topic Course Course Materials Readings
Introduction to Applied Pharmacokinetics MPAS 650 Slides    Sample Questions    Vancomycin Example Ref. #1
Renal Function Assessment Slides    Equations    Cases
Therapeutic Drug Monitoring PHAR:8370 IP Respiratory Slides    Equations    Cases    Sample TDM Questions Ref. #1
Vancomycin & Aminoglycoside CPK Vancomycin Slides    Aminoglycoside Slides    Vancomycin Cases    Aminoglycoside Cases    CPK-Equations    Additional Antibiotic Cases Ref. #2
Clinical Pharmacokinetics and Hepatic Disease PHAR:8372 IP GI and Nutrition Slides    Problem Set Cases Ref. #3, Ref. #4
Clinical Pharmacokinetics and Renal Disease PHAR:8373 IP Renal and Electrolytes Slides    Renal Disease Problem Set
Readings
  1. General Approaches to Clinical Parmacokinetic Monitoring In: Pharmacokinetics in Drug Discovery and Development, Schoenwald RD, editor. Boca Raton: CRC Press, 2002, pp 115-126
  2. Sawchuk RJ, Zaske DE. Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients. J Pharmacokinet Biopharm. 1976 Apr;4(2):183-95. doi: 10.1007/BF01086153.
  3. Drug Biotransformation Review, Personal Notes, Larry Fleckenstein
  4. Mehvar R. Clearance Concepts: Fundamentals and Application to Pharmacokinetic Behavior of Drugs. J Pharm Pharm Sci. 2018;21(1s):88s-102s. doi:10.18433/jpps29896.
Care of the Burn Patient - PHAR:8251 IP: Dermatology
Lectures: Community and Inpatient Focused
Practice Guidelines - Interantional Society of Burn Injury (ISBI)

2016 Guideline

  • ISBI Practice Guidelines Committee. ISBI Practice Guidelines for Burn Care. Burns. 2016 Aug;42(5):953-1021.
  • This guideline addresses the management of hospitalized burn patients.

2018 Guideline

  • ISBI Practice Guidelines Committee. ISBI Practice Guidelines for Burn Care, Part 2. Burns. 2018 Nov;44(7):1617-1706.
  • This guideline provides additional information about special types of burns, more information on infections, sedation and pain management as well as providing information for first aid and topical treatments.
Learning Resources

Treatment of Minor Burns and Sunburns

  • Chapter 41, Minor Burns, Sunburns and Wounds in the Handbook of Nonprescription Drugs, 19th edition.
  • Good review of non-prescription treatments of minor burns and sunburns.

ABA Burn Center Referral Criteria

  • Criteria identifying when patients can be treated locally or should be referred to an ABA certified treatment center.
Additional Resources

American Burn Association Resources

Professional Discovery 1: Introduction Á Background (PHAR:8151)

Objective:

Professional Discovery I students will develop skills in the scientific method, hypothesis testing, presentation of scientific knowledge in written and verbal form, and analysis of clinical study design.

Course Glossary

Definitions of Study Types
  • Meta-analysis: A statistical technique that summarizes the results of several studies in a single weighted estimate, in which more weight is given to results of studies with more events and sometimes to studies of higher quality.
  • Systematic Review: a review in which specified and appropriate methods have been used to identify, appraise, and summarize studies addressing a defined question. (It can, but need not, involve meta-analysis). In Clinical Evidence, the term systematic review refers to a systematic review of RCTs unless specified otherwise.
  • Randomized Controlled Trial: a trial in which participants are randomly assigned to two or more groups: at least one (the experimental group) receiving an intervention that is being tested and another (the comparison or control group) receiving an alternative treatment or placebo. This design allows assessment of the relative effects of interventions.
  • Controlled Clinical Trial: a trial in which participants are assigned to two or more different treatment groups. In Clinical Evidence, we use the term to refer to controlled trials in which treatment is assigned by a method other than random allocation. When the method of allocation is by random selection, the study is referred to as a randomized controlled trial (RCT). Non-randomized controlled trials are more likely to suffer from bias than RCTs. Sometimes referred to as open-labeled controlled trials.
  • Cohort Study: a non-experimental study design that follows a group of people (a cohort), and then looks at how events differ among people within the group. A study that examines a cohort, which differs in respect to exposure to some suspected risk factor (e.g. smoking), is useful for trying to ascertain whether exposure is likely to cause specified events (e.g. lung cancer). Prospective cohort studies (which track participants forward in time) are more reliable than retrospective cohort studies. Sometimes referred to as follow-up studies.
  • Case control study: a study design that examines a group of people who have experienced an event (usually an adverse event) and a group of people who have not experienced the same event, and looks at how exposure to suspect (usually noxious) agents differed between the two groups. This type of study design is most useful for trying to ascertain the cause of rare events, such as rare cancers.
  • Case Series: analysis of series of people with the disease (there is no comparison group in case series).
Every Research Study Answers a Clinical Question
  • Clinical questions may be categorized as either background or foreground. Why is this important?
  • Determining the type of question will help you to select the best study type to achive your answer
  • Background questions ask for general knowledge about an illness, disease, condition, process or thing. These types of questions typically ask who, what, where, when, how & why about things like a disorder, test, or treatment, etc. For example:
  •      - How overweight is a woman to be considered slightly obese?
  •      - What are the clinical manifestations of menopause?
  •      - What causes migraines?
  • Foreground questions ask for specific knowledge to inform clinical decisions. These questions typically concern a specific patient or particular population. Foreground questions tend to be more specific and complex compared to background questions. Quite often, foreground questions investigate comparisons, such as two drugs, two treatments, two diagnostic tests, etc. Foreground questions may be further categorized into one of 4 major types: treatment/therapy, diagnosis, prognosis, or etiology/harm. For example:
  •      - Is Crixivan effective when compared with placebo in slowing the rate of functional impairment in a 45 year old male patient with Lou Gehrig's Disease?
  •      - In pediatric patients with Allergic Rhinitis, are Intranasal steroids more effective than antihistamines in the management of Allergic Rhinitis symptoms?
  • Foreground questions can be further divided into questions that relate to therapy, diagnosis, prognosis, etiology/harm
  •      Therapy: Questions of treatment in order to achieve some outcome. May include drugs, surgical intervention, change in diet, counseling, etc.
  •      Diagnosis: Questions of identification of a disorder in a patient presenting with specific symptoms.
  •      Prognosis: Questions of progression of a disease or likelihood of a disease occurring.
  •      Etiology/Harm: Questions of negative impact from an intervention or other exposure.
  • Knowing the type of foreground question can help you select the best study design to answer your question. You always want to look for the study design that will yield the highest level of evidence. Consult the pyramid and the definitions below.
Formulating a Well-Built Clinical Question

According to the Centre for Evidence Based Medicine (CEBM), "one of the fundamental skills required for practicing EBM is the asking of well-built clinical questions. To benefit patients and clinicians, such questions need to be both directly relevant to patients' problems and phrased in ways that direct your research to relevant and precise answers."

A well-built clinical foreground question should have all four components. The PICO model is a helpful tool that assists you in organizing and focusing your foreground question into a searchable terms for a drug information query or dveloping a researchable topic. Here is the PICO model:

  • P = Patient, Problem, Population (How would you describe the group of patients? What are the most important characteristics of these patient?)
  • I = Intervention, Prognostic Factor, Exposure (What main intervention are you considering? What do you want to do with this patient?)
  • C = Comparison (How are you hoping to make the comparison with the intervention and another treatment, drug, placebo, a different diagnostic test, etc.? It's important to include the methodology (study design) for the comparison.)
  • O = Outcome (What are you trying to accomplish, measure, improve or affect? Outcomes may be disease-oriented or patient-oriented.)

Evidence based medicine (EBM) has developed a levels of evidence pyramid to facilitate the understanding of the types of clinical questions and how they relate to study designs. The PICO model is a helpful tool that assists you in organizing and focusing your foreground question into a searchable terms for a drug information query or dveloping a researchable topic. Here is the PICO model:

Responsive image

The diagram below illustrates how some of the study types mentioned above can be prospective and some retrospective and how they relate to the pyramid of evidence.
Responsive image

Elective Clerkship: Institutional Review Board (IRB) and Drug Information (PHAR:9406)

Site Type
PHAR:9406 Elective Clerkship
Drug Information & Pharmacy Research
Site Location
UIHC Drug Information Center - C108 GH
Iowa City, IA
Site Hours
8 am – 4:30 pm, Monday through Friday
May occasionally require time outside of the rotation to complete some assignments.
Site Contact
Ronald A. Herman, Clinical Pharmacy Specialist
Ronald-A-Herman@uiowa.edu
Site Information

The University of Iowa Hospitals and Clinics is an 800+ bed tertiary care teaching hospital. The site is devoted to help students discover the skills and knowledge they need to become future pharmacy practitioners and researchers. A major focus of the experience is to expose students to the role of safe medical research through the review and approval of all proposed research that involves medications being used in humans. The Institutional Review Board (IRB) approve all research protocols and the preceptor will approve each of them from the Pharmacy & Therapeutics Committee perspective. Students and residents are exposed to the research process from the design and safety perspective and how these issues might impact pharmacy. A portion of the experience is also spent providing back-up coverage in the hospital drug information center.

Clerkship Description

Students who will practice in a hospital or a clinical practice environment will benefit from this rotation:

  1. Time will be spent learning about research protocols, how to design them and how to evaluate them.
  2. The student will help review some of these protocols from the perspective of how they might impact pharmacy.
  3. Additional time will be spent providing back-up coverage in the hospital drug information center.
Clerkship Requirements (Prerequisites)

All rotation students must have a UIHC student ID badge in order to participate in rotations at the UIHC. If you have a UIHC student ID badge from a previous rotation at the UIHC, bring it with you. If you have never had an UIHC student ID badge, stop by the UIHC Pharmacy Administrative Offices (CC101GH, just south of the compass and Elevator B) to obtain the paperwork after 8:00 am on the first day of the rotation. Badging hours are Monday – Friday from 7:30 am to 5:00 pm.

APPE Students Only:
All students will need to complete Epic training prior to their first rotation at UIHC. Epic is our computerized medical record. Students will only need to complete this the first time that they are starting a rotation at UIHC. The training is done on-line by viewing a series of videos and then working in the Epic Playground site. The videos can only be viewed on UIHC computers so you will not be able to complete this prior to the start of the rotation. Computers are available either with your preceptor or in the student room at UIHC. Please bring earbuds or headphones as you may be on a computer in a room with other students watching the videos. Please contact Betsy Beltz (elizabeth-beltz@uiowa.edu) to get specific information for this training for your particular cycle.

PLEASE NOTE: YOU MUST COMPLETE THIS TRAINING EVEN IF YOU HAVE ATTENDED A PREVIOUS EPIC TRAINING SESSION FOR EMPLOYMENT REASONS OR RESEARCH PURPOSES.

Elective Clerkship: Pharmacy Practice for Underserved Populations (PHAR:9434)

Site Type
PHAR:9434 Elective Clerkship
Pharmacy Practice for Underserved Populations
Elective: Underserved Populations
Site Location
UIHC Drug Information Center
and various possible international locations
Site Hours
8 am – 4:30 pm, Monday through Friday
During pre- and post- trip prepartions with Dr. Herman
Site Contact
Ronald A. Herman, Clinical Pharmacy Specialist
Ronald-A-Herman@uiowa.edu
Site Information

Dr. Herman partners with Global Health Outreach which sends out about 50 medical teams to many parts of the world. They typical team has about 5 physicians, 5 dentists, 4 nurses, 2 pharmacists and several logistics personnel. Trips to Latin or South Americal are generally one week in length while trips to Africa and Asia are two weeks in length. The balance of the clerkship rotation is spent in pre-trip preparation and post-trip documentation and publication of the experience. The possible sites that can be arrange can be found on the Global Health Outreach website.

Clerkship Description

The student will spend time before and after the time at the underserved population at Dr. Herman’s normal place of practice, either at the College of Pharmacy or at the drug information center in the Department of Pharmaceutical Care at The University of Iowa Hospitals and Clinics. The location and length of time spent serving an underserved population will be negotiated with the group that the student and preceptor will participate with. Generally, Dr. Herman participates with Global Health Outreach (GHO). They send out about 50 medical teams a year that provide primary health care services in a variety of underserved areas. The teams (which include physicians, dentists, nurses, pharmacists and logistics personnel) that travel to Africa and Asia are generally 2 weeks in length and the teams that travel to Latin or South America are one week in length. The student and preceptor are each responsible for the costs associated with the trips. There are a variety of University and private sources that help cover the expenses. Generally the 2 week trips cost about $4,500 and the one week trips about $2500. That includes foreign and domestic travel, meals, accommodations, the processing of all government red-tape in the host country and the cost of medications that will be used on the trip. In addition, the University requires a $400 fee to process class credit and provide insurance for the student. Note that the student will need to apply for the trip and be accepted at least 2-3 months in advance of the scheduled trip.

Clerkship Requirements (Prerequisites)

P4 standing. Also the student will need to work with the preceptor well in advance to select the trip, apply for the trip according to the partnering organizations procedures, agree to the code of conduct of the partnering organization, agree to the fees associated with the trip, and agree to fully participate with the trip scheduled activities.